Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Irinotecan
Ovarian Disorder
Xiaoxiang Chen
P3
BBB
(72)
Irinotecan
Primary Peritoneal Carcinoma
Tianjin Medical University Cancer Institute and Hospital
P3
BBB
(72)
Irinotecan
Breast Carcinoma
OHSU Knight Cancer Institute
P3
BBB
(72)
Letrozole
Ovarian Serous Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P3
BBB
(72)
Melatonin
Sleep Disorder
Duke University
P3
BBB
(72)
Melphalan
Follicular Lymphoma
H. Lee Moffitt Cancer Center and Research Institute
P3
BBB
(72)
Melphalan
Mantle Cell Lymphoma
Ruijin Hospital
P3
BBB
(72)
Melphalan
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center
P3
BBB
(72)
Melphalan
T-Cell Non-Hodgkin Lymphoma
Sichuan University
P3
BBB
(72)
Melphalan
Disease Related To Hematopoietic Stem Cell Transplant
Institute of Hematology & Blood Diseases Hospital, China
P3
BBB
(72)
Methotrexate
Disease Related To Hematopoietic Stem Cell Transplant
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
P3
BBB
(72)
Methotrexate
B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)
Novartis Pharmaceuticals
P3
BBB
(72)
Nivestim
Acute Monocytic Leukemia
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
P3
BBB
(72)
Nivestim
HIV Infectious Disease
Fred Hutchinson Cancer Center
P3
BBB
(72)
Nivestim
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota
P3
BBB
(72)
Nivolumab
Lung Adenocarcinoma
Emory University
P3
BBB
(72)
Nivolumab
Cancer
Exelixis
P3
BBB
(72)
Nivolumab
Metastatic Malignant Neoplasm In The Brain
Stanford University
P3
BBB
(72)
Nivolumab
Classic Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BBB
(72)
Nivolumab
Cutaneous Melanoma
Fred Hutchinson Cancer Center
P3
BBB
(72)
Nivolumab
Colon Carcinoma
IFOM ETS - The AIRC Institute of Molecular Oncology
P3
BBB
(72)
Nivolumab
Colorectal Neoplasm
Bristol-Myers Squibb
P3
BBB
(72)
Nivolumab
Ovarian Carcinoma
Instituto do Cancer do Estado de São Paulo
P3
BBB
(72)
Nivolumab
Fallopian Tube Cancer
Regeneron Pharmaceuticals
P3
BBB
(72)
Nivolumab
Head And Neck Cancer
Fate Therapeutics
P3
BBB
(72)
Showing 2101 to 2125 of 42,286 assets
Previous
Page 85 of 1692
Next